Early treatment response assessment with [177Lu]PSMA whole-body-scintigraphy compared to interim PSMA-PET Ventura D, Rassek P, Schindler P, Akkurt BH, Bredensteiner L, Bögemann M, Schlack K, Seifert R, Schäfers M, Roll W, Rahbar K (2024) In: Cancer Imaging, 18(24(1)). Forschungsartikel (Zeitschrift)
The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Boegemann M, Schlack K, Thomes S, Steinestel J, Rahbar K, Semjonow A, Schrader AJ, Aringer M, Krabbe LM (2017) In: ((Bitte Journal prüfen)), 18. Forschungsartikel (Zeitschrift)
The safety and efficacy of gemcitabine for the treatment of bladder cancer Schlack K, Boegemann M, Steinestel J, Schrader AJ, Krabbe LM (2016) In: ((Bitte Journal prüfen)), 16(3). Forschungsartikel (Zeitschrift)
The role of fPSA, [-2]proPSA and the Prostate Health Index for the early prediction of outcome in patients with metastatic castration resistant prostate cancer on therapy with abirateroneacetate. Schlack K, Krabbe LM, Eminaga O, Semjonow A, Boegemann M (2016) In: ASCO-GU, San Francisco. Abstract in Online-Sammlung (Konferenz)
Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate Boegemann M, Schlack K, Fischer AK, Gerß J, Steinestel J, Semjonow A, Schrader AJ, Krabbe LM (2016) In: PloS one, 11. Forschungsartikel (Zeitschrift)